Viewing Study NCT02362412

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:11 PM
Ignite Modification Date: 2026-03-13 @ 3:51 AM
Study NCT ID: NCT02362412
Status: COMPLETED
Last Update Posted: 2024-11-15
First Post: 2015-02-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bipolar Depression View
Keywords:

Keywords

Keyword Brief Keyword Text View
None major depressive episodes View
None FK949E View
None quetiapine View
None bipolar depression View
None bipolar disorder View